[go: up one dir, main page]

CN101711792B8 - 一种治疗冠心病的滴丸及其制备方法 - Google Patents

一种治疗冠心病的滴丸及其制备方法 Download PDF

Info

Publication number
CN101711792B8
CN101711792B8 CN200910179090.4A CN200910179090A CN101711792B8 CN 101711792 B8 CN101711792 B8 CN 101711792B8 CN 200910179090 A CN200910179090 A CN 200910179090A CN 101711792 B8 CN101711792 B8 CN 101711792B8
Authority
CN
China
Prior art keywords
weight percentage
percentage content
dripping pill
heart disease
plasticizing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN200910179090.4A
Other languages
English (en)
Other versions
CN101711792A (zh
CN101711792B (zh
Inventor
陈建明
闫希军
朱永宏
高保安
章顺楠
董海欧
张继仲
李伟
颜新江
赵颖
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tasly Pharmaceutical Group Co Ltd
Original Assignee
Tasly Pharmaceutical Group Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tasly Pharmaceutical Group Co Ltd filed Critical Tasly Pharmaceutical Group Co Ltd
Priority to CN200910179090.4A priority Critical patent/CN101711792B8/zh
Publication of CN101711792A publication Critical patent/CN101711792A/zh
Publication of CN101711792B publication Critical patent/CN101711792B/zh
Application granted granted Critical
Publication of CN101711792B8 publication Critical patent/CN101711792B8/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

本发明涉及一种治疗冠心病的滴丸，由药物活性成分、基质辅料、增塑性成分、丙二醇和水组成：其中药物活性成分由丹参、三七和冰片制成；基质辅料为赤藓糖醇；增塑性成分选自聚乙二醇类、木糖醇、乳糖醇、甘露醇、甘油、可溶性淀粉、明胶、甲基纤维素、羧甲基纤维素钠、羟丙基甲基纤维素、阿拉伯胶、海藻酸、糊精、环糊精、枸橼酸酯、醋酸甘油酯、癸二酸二丁酯、精制椰子油和蓖麻油中的一种或几种；其中，相对于滴丸的总重量，药物活性成分的重量百分含量为1-40％，增塑性成分的重量百分含量为0-10％，丙二醇的重量百分含量为1-10％，水的重量百分含量为0-10％，其余为基质辅料。本发明的滴丸安全无毒、吸湿性低、溶散速度快。
CN200910179090.4A 2008-10-06 2009-09-30 一种治疗冠心病的滴丸及其制备方法 Active CN101711792B8 (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200910179090.4A CN101711792B8 (zh) 2008-10-06 2009-09-30 一种治疗冠心病的滴丸及其制备方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN200810152009 2008-10-06
CN200810152009.9 2008-10-06
CN200910179090.4A CN101711792B8 (zh) 2008-10-06 2009-09-30 一种治疗冠心病的滴丸及其制备方法

Publications (3)

Publication Number Publication Date
CN101711792A CN101711792A (zh) 2010-05-26
CN101711792B CN101711792B (zh) 2012-08-22
CN101711792B8 true CN101711792B8 (zh) 2020-12-22

Family

ID=42416040

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200910179090.4A Active CN101711792B8 (zh) 2008-10-06 2009-09-30 一种治疗冠心病的滴丸及其制备方法

Country Status (1)

Country Link
CN (1) CN101711792B8 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104147111A (zh) * 2013-05-14 2014-11-19 天士力制药集团股份有限公司 复方丹参滴丸治疗氧化应激损伤
EP3020407A4 (en) 2013-07-11 2017-05-03 Tasly Pharmaceutical Group Co., Ltd. Traditional chinese medicine composition, and preparation and application thereof
MX376094B (es) 2013-07-11 2025-03-07 Talsy Pharmaceutical Group Co Ltd Composición de medicina china tradicional, y preparación y aplicación de la misma.
CN104274519B (zh) * 2013-07-11 2018-04-03 天士力医药集团股份有限公司 振动法制备复方丹参滴丸
CA2916423C (en) 2013-07-11 2021-10-26 Tasly Pharmaceutical Group Co., Ltd. Formulation of a micro drop pill and the preparation method thereof
CN117159604A (zh) * 2023-09-27 2023-12-05 哈尔滨珍宝制药有限公司 一种用于脑血栓恢复期的中药组合物

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1348815A (zh) * 2001-11-09 2002-05-15 天津天士力制药股份有限公司 一种预防和治疗冠心病心绞痛的药物及其制备方法和其它用途

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1348815A (zh) * 2001-11-09 2002-05-15 天津天士力制药股份有限公司 一种预防和治疗冠心病心绞痛的药物及其制备方法和其它用途

Also Published As

Publication number Publication date
CN101711792A (zh) 2010-05-26
CN101711792B (zh) 2012-08-22

Similar Documents

Publication Publication Date Title
CN101711792B8 (zh) 一种治疗冠心病的滴丸及其制备方法
JP6598841B2 (ja) ツーピース硬カプセル用の耐酸性バンド溶液
CN102036654B (zh) 稳定的非典型抗精神病制剂
CN101652141A (zh) 他克莫司的调节释放剂型
CN102065847A (zh) 含有血管紧张素-ⅱ受体阻断剂的药物制剂
KR20100094981A (ko) 간염치료용 실리비닌 성분
JP2015509909A5 (zh)
DE102008023345A1 (de) Filmförmige Zubereitung mit öligen Substanzen zur oralen Verabreichung
JP2015514797A5 (zh)
JP2020535162A5 (zh)
AU2005206063A1 (en) Method of preparing low-crystallinity oltipraz or amorphous oltipraz
CN102451162A (zh) 经口腔粘膜吸收的奥氮平药物
JP6441811B2 (ja) 複合体形成用組成物、そこから形成された複合体、及びそれを含む経口摂取用組成物
CN1626122A (zh) 一种治疗心脑血管疾病的药物
JP2013129627A (ja) フロロタンニン類の簡易な調製方法とその利用
JP2007529564A5 (zh)
CN101984980B (zh) 一种贯叶连翘提取物的提取方法、提取物和制药用途
CN107281150A (zh) 一种降血脂的辛伐他汀缓释片及其制备方法
US20230270678A1 (en) Pharmaceutical compositions for improved delivery of therapeutic lipophilic actives
CN105078944A (zh) Isopaucifloral F在制备抗骨质疏松药物中的用途
JP6926453B2 (ja) カプセル組成物
WO2008012474A3 (fr) Compositions pharmaceutiques de substances actives difficilement detournables de la voie d'administration a laquelle elles sont destinees
CN114945353A (zh) 高亲脂性生理活性物质的控释制剂
JP6404826B2 (ja) 放出制御能を有する製剤およびその製造方法
CN103099796A (zh) 含有苷糖酯的缓释制剂及其制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1142271

Country of ref document: HK

C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee

Owner name: TASLY PHARMACEUTICAL GROUP CO., LTD.

Free format text: FORMER NAME: TIANJIN TASLY PHARM. CO., LTD.

CP01 Change in the name or title of a patent holder

Address after: 300410 Tianjin City Hedong District of Beichen Puji Road No. 2 city of the modern Chinese Medicine

Patentee after: TASLY PHARMACEUTICAL GROUP Co.,Ltd.

Address before: 300410 Tianjin City Hedong District of Beichen Puji Road No. 2 city of the modern Chinese Medicine

Patentee before: TIANJIN TASLY PHARMACEUTICAL Co.,Ltd.

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1142271

Country of ref document: HK

CP01 Change in the name or title of a patent holder

Address after: 300410 Tianjin City Hedong District of Beichen Puji Road No. 2 city of the modern Chinese Medicine

Patentee after: TASLY PHARMACEUTICAL GROUP Co.,Ltd.

Address before: 300410 Tianjin City Hedong District of Beichen Puji Road No. 2 city of the modern Chinese Medicine

Patentee before: TASLY PHARMACEUTICAL GROUP Co.,Ltd.

CP01 Change in the name or title of a patent holder
CI03 Correction of invention patent

Correction item: Inventor

Correct: Chen Jianming|Yan Xijun|Zhu Yonghong|Gao Baoan|Zhang Shunnan|Dong Haiou|Zhang Jizhong|Li Wei|Yan Xinjiang|Zhao Ying

False: Chen Jianming|Yan Xijun|Zhu Yonghong|Gao Baoan|Zhang Shunnan|Dong Haiou|Zhang Jizhong|Li Wei|Yanxinjiang|Zhao Ying

Number: 34

Page: The title page

Volume: 28

Correction item: Inventor

Correct: Chen Jianming|Yan Xijun|Zhu Yonghong|Gao Baoan|Zhang Shunnan|Dong Haiou|Zhang Jizhong|Li Wei|Yan Xinjiang|Zhao Ying

False: Chen Jianming|Yan Xijun|Zhu Yonghong|Gao Baoan|Zhang Shunnan|Dong Haiou|Zhang Jizhong|Li Wei|Yanxinjiang|Zhao Ying

Number: 34

Volume: 28

CI03 Correction of invention patent